1,10-phenanthroline has been researched along with Bronze Diabetes in 1 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groborz, O | 1 |
| Poláková, L | 1 |
| Kolouchová, K | 1 |
| Švec, P | 1 |
| Loukotová, L | 1 |
| Miriyala, VM | 1 |
| Francová, P | 1 |
| Kučka, J | 1 |
| Krijt, J | 1 |
| Páral, P | 1 |
| Báječný, M | 1 |
| Heizer, T | 1 |
| Pohl, R | 1 |
| Dunlop, D | 1 |
| Czernek, J | 1 |
| Šefc, L | 1 |
| Beneš, J | 1 |
| Štěpánek, P | 1 |
| Hobza, P | 1 |
| Hrubý, M | 1 |
1 other study available for 1,10-phenanthroline and Bronze Diabetes
| Article | Year |
|---|---|
Chelating Polymers for Hereditary Hemochromatosis Treatment.
Topics: Benzene; Gastrointestinal Tract; Hemochromatosis; Humans; Iron; Iron Chelating Agents; Models, Theor | 2020 |